Area of research
Epidemiology · Hepatology
Research interest
Research focused on Cirrhosis and Fibrosis, with related work in Portal hypertension, Nornicotine, Immunogenicity. Notable publications include 'Baveno VII – Renewing consensus in portal hypertension', 'Resolving the fibrotic niche of human liver cirrhosis at single-cell level', and 'Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis'.
Hepatic stellate cells control liver zonation, size and functions via R-spondin 3
A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liver
Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approach
Single-nucleus RNA sequencing of pre-malignant liver reveals disease-associated hepatocyte state with HCC prognostic potential
Baveno VII – Renewing consensus in portal hypertension
Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study
Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study
Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: A multicenter cohort study
Resolving the fibrotic niche of human liver cirrhosis at single-cell level
Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis